Radioimmunotherapy with I-131-anti-B1 (anti CD20) antibody decreases spleen size in patients with non-Hodgkin's lymphoma

被引：0
|
作者：
Zasadny, KR
Gates, VL
Kaminski, MS
Wahl, RL
机构：
来源：
RADIOLOGY | 1998年 / 209P卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1007
引用
收藏
页码：367 / 368
页数：2
相关论文
共 50 条
  • [1] Radioimmunotherapy (RIT) of non-Hodgkin's lymphoma (NHL) with I-131 anti-CD20 monoclonal antibody (Bexxar™).: Preliminary results
    Antonescu, C
    Buchegger, F
    Kosinski, M
    Ketterer, N
    Kovacsovics, T
    Helg, C
    Delaloye, AB
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 980 - 980
  • [2] Randomized controlled study of I-131-Anti-B1 versus unlabeled-Anti-B1 monoclonal antibody in patients with chemotherapy refractory low grade non-Hodgkin's lymphoma
    Knox, SJ
    Goris, ML
    Davis, TA
    Trisler, KD
    Saal, J
    Levy, R
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 326 - 326
  • [3] Do tracer dosimetry studies predict normal organ and tumor uptake of I-131-anti-B1 (anti CD-20) antibody in patients receiving radioimmunotherapy for non-Hodgkins lymphoma?
    Zasadny, KR
    Gates, VL
    Moon, S
    Regan, DD
    Kaminski, MS
    Wahl, RL
    RADIOLOGY, 1997, 205 : 509 - 509
  • [4] RADIOIMMUNOTHERAPY OF B-CELL LYMPHOMA WITH [I-131] ANTI-B1 (ANTI-CD20) ANTIBODY
    KAMINSKI, MS
    ZASADNY, KR
    FRANCIS, IR
    MILIK, AW
    ROSS, CW
    MOON, SD
    CRAWFORD, SM
    BURGESS, JM
    PETRY, NA
    BUTCHKO, GM
    GLENN, SD
    WAHL, RL
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (07): : 459 - 465
  • [5] RADIOIMMUNOTHERAPY OF REFRACTORY B-CELL LYMPHOMA WITH 131-I-ANTI-B1 (ANTI-CD20) ANTIBODY
    KAMINSKI, MS
    FENNER, M
    ZASADNY, KR
    MILIK, AW
    ROSS, CW
    FRANCIS, IR
    BURGESS, J
    ESTES, J
    CRAWFORD, S
    HODUL, P
    COOK, R
    REGAN, D
    PETRY, N
    GLENN, S
    BUTCHKO, G
    WAHL, RL
    CLINICAL RESEARCH, 1994, 42 (03): : A405 - A405
  • [6] Metabolic response of non-Hodgkin's lymphoma to 131I-anti-B1 radioimmunotherapy:: Evaluation with FDG PET
    Torizuka, T
    Zasadny, KR
    Kison, PV
    Rommelfanger, SG
    Kaminski, MS
    Wahl, RL
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (06) : 999 - 1005
  • [7] Radiobiology of radioimmunotherapy: Targeting CD20 B-cell antigen in non-Hodgkin's lymphoma
    Hernandez, MC
    Knox, SJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (05): : 1274 - 1287
  • [8] Anti-CD20 monoclonal antibody therapy for non-Hodgkin's lymphoma
    White, CA
    Weaver, R
    Royston, I
    MINERVA BIOTECNOLOGICA, 1998, 10 (03) : 108 - 116
  • [9] Radioimmunotherapy of B-lineage non-Hodgkin's lymphoma using anti-CD19 and anti-CD20 conjugates.
    Heeger, SW
    Moldenhauer, G
    Flynn, JM
    Egerer, G
    Nikula, T
    Apostolidis, C
    Brechbiel, M
    Haberkorn, U
    Ho, AD
    Haas, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 194S - 194S
  • [10] Normal organ and tumor dosimetry of I-131-anti-B1 (anti-CD20) radioimmunotherapy at non-marrow ablative doses.
    Zasadny, KR
    Gates, VL
    Francis, I
    Fisher, S
    Kaminski, MS
    Wahl, RL
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 977 - 977
12345